/Bio-Rad%20Laboratories%20Inc_%20logo%20and%20site-by%20T_Schneider%20via%20Shutterstock.jpg)
Based in Hercules, California, Bio-Rad Laboratories, Inc. (BIO) is a prominent life science player known for its innovative products and solutions that advance scientific research and clinical diagnostics. With a market cap of $8.57 billion, Bio-Rad Laboratories is renowned for its contributions to enhancing laboratory efficiency and accuracy through state-of-the-art technologies. The company is set to announce its fiscal Q2 earnings results after the market closes on Thursday, Aug. 1.
Ahead of the event, analysts expect BIO to report a profit of $2.12 per share, down 29.3% from $3 per share in the year-ago quarter. In the last four quarters, the company has surpassed Wall Street’s bottom-line estimates in three and missed on another occasion.